Short answer
10x Genomics, Inc. (TXG) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results for quarter ended March 31, 2026.
10x Genomics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results for quarter ended March 31, 2026
- Press release attached as Exhibit 99.1 for revenue, earnings, guidance, and operating details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other 10x Genomics, Inc. 8-K filings
Get the next TXG 8-K as it lands
Follow TXG for push alerts, or ask the research agent what this filing means.